Marketable Securities, Current of Gain Therapeutics, Inc. from 30 Jun 2022 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Gain Therapeutics, Inc. quarterly Marketable Securities, Current in USD history and change rate from 30 Jun 2022 to 31 Mar 2024.
  • Gain Therapeutics, Inc. Marketable Securities, Current for the quarter ending 31 Mar 2024 was $2,019,414, a 83% decline year-over-year.
Source SEC data
View on sec.gov
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,019,414 -$9,808,114 -83% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $4,999,704 -$7,827,250 -61% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $7,960,311 -$3,890,303 -33% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $9,873,209 -$66,287 -0.67% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $11,827,528 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $12,826,954 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $11,850,614 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $9,939,496 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.